Brain ageing in the new millennium

References

• Cattel R. Theory of Fluid and crystallised intelligence: a critical experiment. Journal of Educational Psychology 1963; 54: 1–22
   Web of Science ®Google Scholar
• Horn J. Organization of data on life-span and development of human abilities. Life-span developmental psychology: theory and research, R Goulet, P Baltes. Academic Press, New York 1970
   Google Scholar
• Summers J, Borland R, Walker M. Psychology. John Wiley & Sons, Brisbane 1989
   Google Scholar
• Baltes P, Staudinger U, Lindenberger U. Lifespan psychology: theory and application to intellectual functioning. Annual Review of Psychology 1999; 50: 471–507
   PubMed Web of Science ®Google Scholar
• Zec R. The neuropsychology of aging. Experimental Gerontology 1995; 30: 431–442
   PubMed Web of Science ®Google Scholar
• Stankov L. Aging, attention and intelligence. Psychology and Aging 1988; 3: 59–74
   PubMed Web of Science ®Google Scholar
• Salthouse T. A Theory of cognitive aging. Elsevier Science, Amsterdam 1985
   Google Scholar
• Rabbitt P. Applied cognitive gerontology: some problems, methodologies and data. Applied Cognitive Psychology 1990; 4: 225–246
   Web of Science ®Google Scholar
• Parnetti L, Lowenthal D, Presciutti O, et al. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable alzheimer's disease. Journal of the American Geriatrics Society 1996; 44: 133–138
   PubMed Web of Science ®Google Scholar
• Crook T, Bartus R, Ferris S, et al. Age associated memory impairment: proposed diagnostic criteria and measures of clinical change –Report of a national institute of mental health work group. Developmental Neuropsychology 1986; 2: 261–276
   Web of Science ®Google Scholar
• Shah Y, Tangalos E, Petersen R. Mild cognitive impairment: when is it a precursor to Alzheimer's disease?. Geriatrics 2000; 55: 62–68
   PubMed Web of Science ®Google Scholar
• Petersen R, Smith G, Waring S, et al. Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology 1999; 56: 303–308
   PubMed Web of Science ®Google Scholar
• Baltes P. The aging mind: potential and limits. The Gerontologist 1993; 33: 580–594
   PubMed Web of Science ®Google Scholar
• Freedman M, Knoefel J, Naeser M, . Computerized axial tomography in aging. Clinical Neurology of Aging, M Albert, et al. Oxford University Press, New York 1984; 139–148
   Google Scholar
• Raz N. Neuroanatomy of the aging bra. Neuroimaging II Clinical Applications, E Bigler. Academic Press, New York 1996; 153–182
   Google Scholar
• Forstl H, Zerfab R, Geiger-Kabisch C, et al. rain atrophy in normal ageing and alzheimer's disease: volumetric discrimination and clinical correlations. The British Journal of Psychiatry 1995; 167: 739–746
   PubMed Web of Science ®Google Scholar
• Raz N. Aging of the brain and its impact on cognitive performance: integration of structural and functional findings. The Handbook of Aging and Cognition, F Craik, T Salthouse. Lawrence Erlbaum Associates, New Jersey 2000; 1–90
   Google Scholar
• Raz N, Torres I, Spencer W, et al. Neuroanatomical correlates of age-sensitive and age-invariant cognitive abilities: an in vivo MRI investigation. Intelligence 1993; 17: 407–422
   Web of Science ®Google Scholar
• Cowell P, Tuetsky B, Gur R, et al. Sex differences in aging of the human frontal and temporal lobes. Journal of Neuroscience 1994; 14: 4748–4755
   PubMed Web of Science ®Google Scholar
• Raz N, Gunning F, Head D, et al. Selective aging of human cerebral cortex observed in vivo: Differential vulnerability of the prefrontal gray matter. Cerebral Cortex 1997; 7: 268–282
   PubMed Web of Science ®Google Scholar
• Murphy D, DeCarli C, McIntosh A, et al. ge-related differences in Volumes of subcortical nuclei, brain matter, and cerebro-spinal fluid in healthy men as measured with magnetic resonance imaging (MRI). Archives of General Psychiatry 1996; 53: 585–594
   PubMed Web of Science ®Google Scholar
• Raz N, Gunning-Dixon F, Head D, et al. Neuroanatomical correlates of cognitive aging: Evidence from structural MRI. Neuropsychology 1998; 12: 95–114
   PubMed Web of Science ®Google Scholar
• O'Donnell K, Rapp P, Hof P. Preservation of prefrontal cortical volume in behaviorally characterized aged macaque monkeys. Experimental Neurology 1999; 160: 300–310
   PubMed Web of Science ®Google Scholar
• Bobinski M, Leon M, Convit A, et al. MRI of entorhinal cortex in mild Alzheimer's disease. Lancet 1999; 353: 38–40
   PubMed Web of Science ®Google Scholar
• Convit A, Leon M, Tarshish C, et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiology of Aging 1997; 18: 131–138
   PubMed Web of Science ®Google Scholar
• Amaral D. Introduction: What is where in the medial temporal lobe. Hippocampus 1999; 9: 1–6
   PubMed Web of Science ®Google Scholar
• Reiman E, Caselli R, Yun L, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the E4 allele for apolipoprotein E. New England Journal of Medicine 1996; 334: 752–758
   PubMed Web of Science ®Google Scholar
• Plassman B, Welsh-Bohmer K, Bigler E, et al. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology 1997; 48: 985–999
   PubMed Web of Science ®Google Scholar
• Cohen N, Eichenbaum H. Memory, amnesia, and the hippocampal system. MIT Press, Cambridge 1994
   Google Scholar
• Squire L. Memory and the hippocampus: a synthesis from findings with rats, monkeys and humans. Psychological Review of 1992; 99: 195–231
   PubMed Web of Science ®Google Scholar
• Stern C, Hasselmo M. Bridging the gap: integrating cellular and functional magnetic resonance imaging studies of the hippocampus. Hippocampus 1999; 9: 45–53
   PubMed Web of Science ®Google Scholar
• Juottonen K, Laakso M, Insausti R, et al. Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiology of Aging 1998; 19: 15–22
   PubMed Web of Science ®Google Scholar
• Insausti R, Jouttonen K, Soininen H, et al. MR volume tric analysis of the human entorhinal, perirhinal, and temporopolar cortices. American Journal of Neuroradiology 1998; 19: 659–671
   PubMed Web of Science ®Google Scholar
• Mu Q, Xie J, Wen Z, et al. A Quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40–90 years of age. American Journal of Neuroradiology 1999; 20: 207–211
   PubMed Web of Science ®Google Scholar
• Lim K, Zipursky R, Murphy G, et al. In vivo quantification of the limbic system using MRI: effects of normal aging. Psychiatry Research 1990; 35: 15–26
   PubMed Web of Science ®Google Scholar
• Raz N, Torres I, Acker J. Age, gender, and hemispheric differences in human striatum: a quantitative review and new data from in vivo MRI morphometry. Psychobiology 1995; 21: 151–160
   Google Scholar
• Roth G. Changes in tissue responsiveness to hormones and neurotransmitters during aging. Experimental Gerontology 1995; 30: 361–368
   PubMed Web of Science ®Google Scholar
• Berridge K, Robinson R. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Research –Brain Research Reviews 1998; 28: 309–369
   PubMed Web of Science ®Google Scholar
• Doraiswamy P, Na C, Husain M, et al. Morphometric changes in the human midbrain with normal aging: MR and stereologic findings. American Journal of Neuroradiology 1992; 13: 383–386
   PubMed Web of Science ®Google Scholar
• Weis S, Kimbacher M, Wenger E, et al. Morphometric analysis of the corpus callosum using MR. Correlation of measurements with aging in healthy individuals. American Journal of Neuroradiology 1993; 14: 637–645
   PubMed Web of Science ®Google Scholar
• Salat D, Ward A, Kaye J, et al. Sex differences in the corpus callosum with aging. Neurobiology of Aging 1997; 18: 191–197
   PubMed Web of Science ®Google Scholar
• Alexander J, Sheppard S, Davis P, et al. Adult cerebrovascular disease: role of modified rapid fluid-attenuated inversion recovery sequences. American Journal of Neuroradiology 1996; 17: 1507–1513
   PubMed Web of Science ®Google Scholar
• Pantoni L, Garcia J. Pathogenesis of Leukoaraiosis: a review. Stroke 1997; 28: 652–659
   PubMed Web of Science ®Google Scholar
• Hunt A, Orrison W, Yeo R, et al. Clinical significance of MRI white matter lesions in the elderly. Neurology 1989; 39: 1470–1474
   PubMed Web of Science ®Google Scholar
• Ylikoski A, Erkinjuntti T, Raininko R, et al. White matter hyperintensities on MRI in the neurologically non-diseased elderly: analysis of cohorts of consecutive subjects aged 55–85 years living at home. Stroke 1995; 26: 1171–1177
   PubMed Web of Science ®Google Scholar
• Valenzuela M, Sachdev P, Wen W, et al. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortico-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes. Neuroimage 2000; 12: 747–756
   PubMed Web of Science ®Google Scholar
• Boone K, Miller B L, Lesser I, et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects: a threshold effect. Archives of Neurology 1992; 49: 549–554
   PubMed Web of Science ®Google Scholar
• Ylikoski R, Ylikoski A, Erkinjuntti T, et al. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Archives of Neurology 1993; 50: 818–824
   PubMed Web of Science ®Google Scholar
• Kemper T. Neuroanatomical and neuropathological changes during aging and in dementia. Clinical Neurology of Aging, M Albert, J Knoepfel. Oxford University Press, New York 1994; 3–67
   Google Scholar
• Double K, Halliday G, Kril J, et al. Topography of brain atrophy during normal ageing and Alzheimer's disease. Neurobiology of Aging 1996; 17: 513–521
   PubMed Web of Science ®Google Scholar
• Esiri M. Dementia and normal aging: Neuropathology. Dementia and Normal Aging, F Huppert, C Brayne, D O'Connor. Cambridge University Press, Cambridge 1994; 385–436
   Google Scholar
• Dickson D. Structural Changes in the Aged Bra. Advances in Cell Aging and Gerontology, P Timiras, E Bittar. JAI, Greenwich 1997; 51–76
   Google Scholar
• Peters A, Rosene D, Moss T, et al. Neurobiological bases of age-related cognitive decline in the rhesus monkey. Journal of Neuropathology and Experimental Neurology 1996; 55: 861–874
   PubMed Web of Science ®Google Scholar
• Salthouse T. The processing-speed theory of adult age differences in cognition. Psychological Review 1996; 103: 403–428
   PubMed Web of Science ®Google Scholar
• Selkoe D. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399: A23–A31
   PubMed Web of Science ®Google Scholar
• Weldon D, Maggio J, Mantyh P. New insights into the neuropathology and cell biology of Alzheimer's disease. Geriatrics 1997; 52: S13–S16
   PubMed Web of Science ®Google Scholar
• McGeer P, McGeer E. Autotoxicity Alzheimer's Disease. Archives of Neurology 2000; 57: 789–790
   PubMedGoogle Scholar
• Guillozet A, Smiley J, Mash D, et al. The amyloid burden of the cerebral cortex in non-demented old age. Society for Neuroscience 1995; 21: 1478
   Google Scholar
• Wolozin B, Behl C. Mechanisms of neurodegenerative disorders part 2: control of cell death. Archives of Neurology 2000; 57: 801–804
   PubMed Web of Science ®Google Scholar
• Roher A, Lowenson J, Clarke S, et al. b-Amyloid-(1–42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease. Proceeding of the National Academy of Sciences USA 1993; 90: 10836–10840
   PubMed Web of Science ®Google Scholar
• Dickson D, Crystal H, Mattiace L, et al. Identification of normal and pathological aging in prospectively studied non-demented elderly humans. Neurobiology of Aging 1992; 13: 1–11
   PubMed Web of Science ®Google Scholar
• Troncoso J, Martin L, Dal Forno G, et al. europathology in controls and demented subjects from the Baltimore longitudinal study of aging. Neurobiology of Aging 1996; 17: 365–371
   PubMed Web of Science ®Google Scholar
• Davies L, Molska B, Hilbich C, et al. A4 amyloid deposition and the diagnosis of Alzheimer's disease: prevalence in aged brain determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 1988; 38: 1688–1693
   PubMed Web of Science ®Google Scholar
• Delaere P, He Y, Fayet G, et al. Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. Neurobiology of Aging 1993; 14: 191–194
   PubMed Web of Science ®Google Scholar
• Crystal H, Dickson D, Sliwinski M, et al. Associations of status and change measures of neuropsychological function with pathological changes in elderly, originally non-demented elderly. Archives of Neurology 1996; 53: 82–87
   PubMedGoogle Scholar
• Crystal H, Dickson D, Fuld P, et al. Clinico-pathological studies in dementia: Non-demented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988; 38: 1682–1687
   PubMed Web of Science ®Google Scholar
• Katzman R, Terry R, DeTeresa R, et al. linical, pathological and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Annals of Neurology 1988; 23: 138–144
   PubMed Web of Science ®Google Scholar
• Yen S, Liu W, Hall F, et al. Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components. Neurobiology of Aging 1995; 16: 381–387
   PubMed Web of Science ®Google Scholar
• Dickson D, Singer G, Davies P, . Regional immunocytochemical studies of brains of prospectively studied demented and nondemented elderly humans. Alzheimer's Disease: Advances in Clinical and Basic Research, M Zatta, B Corain, et al. John Wiley, New York 1993; 123–126
   Google Scholar
• Magistretti P, Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philosophical Transactions of the Royal Society of London B 1999; 354: 1155–1163
   PubMed Web of Science ®Google Scholar
• Klein B, Duschinsky W, Schrock H, et al. Interdependency of local capillary density, blood flow and metabolism in rat brains. Americal Journal of Physiology 1986; 251: H1333–H1340
   PubMed Web of Science ®Google Scholar
• Jucker M, Battig K, Meier-Ruge W. Effects of aging and vincamine derivatives on pericapillary environment: stereological characterization of the cerebral capillary network. Neurobiology of Aging 1990; 11: 39–46
   PubMed Web of Science ®Google Scholar
• Fang H. Observations on aging characteristics of cerebral blood vessels, macroscopic and microscopic features. Neurobiology of Aging, R Terry, S Gershon. Raven, New York 1976; 155–166
   Google Scholar
• Hassler O. Vascular changes in senile brains. Acta Pathologica (Berl) 1965; 5: 40–53
   PubMedGoogle Scholar
• de la Torre M. Cerebrovascular Changes in the Aging Bra. Advances in cell aging and gerontology, P Timiras, E Bittar. JAI, Greenwich 1997; 77–107
   Google Scholar
• Mooradian A. Effect of aging on the blood–brain barrier. Neurobiology of Aging 1988; 9: 31–39
   PubMed Web of Science ®Google Scholar
• Klassen A, Sung J, Stadlan E. Histological changes in cerebral arteries with increasing age. Journal of Neuropathology and Experimental Neurology 1968; 27: 607–623
   PubMed Web of Science ®Google Scholar
• Naritomi H, Meyer J S, Kumihiko S, et al. Effects of advancing age on regional cerebral blood flow. Archives of Neurology 1979; 36: 410–416
   PubMed Web of Science ®Google Scholar
• NHMRC. Clinical Practice Guidelines –Prevention of Stroke 1996, www.health.gov.au:80/nhmrc/publicat/synopses/cp45to47.htm
   Google Scholar
• Kuschinsky W, Paulson O. Capillary circulation in the brain. Cerebrovascular Brain Metabolism Review of 1992; 4: 163–171
   Google Scholar
• Scharrer E. The blood vessels of the nervous system. Quarterly Review of Biology 1944; 19: 308–318
   Google Scholar
• Grammas P. A damaged microcirculation contribut es to neuronal cell death in Alzheimer's disease. Neurobiology of Aging 2000; 21: 199–205
   PubMed Web of Science ®Google Scholar
• Sparks D, Scheff S, Liu H, et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. Journal of the Neurological Sciences 1995; 131: 162–169
   PubMed Web of Science ®Google Scholar
• de la Torre J C. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis. Neurobiology of Aging 2000; 21: 331–342
   PubMed Web of Science ®Google Scholar
• Zakeri Z, Locksin R. Physiological cell death during development and its relationship to aging. Annals of the New York Academy of Sciences 1994; 719: 212–229
   PubMed Web of Science ®Google Scholar
• Warner H, Hodes R, Pocinki K. What does cell death have to do with aging?. Journal of American Geriatrics Society of 1997; 45: 1140–1146
   PubMed Web of Science ®Google Scholar
• Morrison J, Hof P. Life and death of neurons in the aging brain. Science 1997; 278: 412–419
   PubMed Web of Science ®Google Scholar
• Sterio D. The unbiased estimation of number and sizes of arbitrary particles using the disector. Journal of Microscopy 1984; 134: 127–136
   PubMed Web of Science ®Google Scholar
• West M. Stereological methods for estimating the total number of neurons ans synapses: issues of precision and bias. Trends in Neurosciences 1999; 22: 51–61
   PubMed Web of Science ®Google Scholar
• Wickelgren I. Is hippocampal cell death a myth?. Science 1999; 271: 1229–1230
   Web of Science ®Google Scholar
• Long J, Mouton P, Jucker M, et al. What counts in brain aging? Design-based stereological analysis of cell number. Journal of Gerontology: Biological Sciences 1999; 54A:B407–B417
   Web of Science ®Google Scholar
• Rapp P, Gallagher M. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proceeding of the National Academy of Sciences USA 1996; 93: 9926–9930
   PubMed Web of Science ®Google Scholar
• Rasmussen T, Scliemann T, Sorensen J, et al. Memory impaired aged rats: no loss of principal hippocampal and subicular neurons. Neurobiology of Aging 1996; 17: 143–147
   PubMed Web of Science ®Google Scholar
• Hamrick J, Sullivan P, Scheff S. Estimation of possible agerelated changes in synaptic density in the hippocampal CA1 stratum radiatum. Society of for Neuroscience Abstract 1998; 24: 783
   Google Scholar
• Wickett J, Vernon P. Peripheral Nerve Conduction Velocity, Reaction Time, and Intelligence: An Attempt to Replicate Vernon and Mori. Intelligence 1994; 18: 127–131
   Web of Science ®Google Scholar
• Laming P, Sykova E, Reichenbach A, et al. Glial cells: their role in behaviour. Cambridge University Press, Cambridge 1998
   Google Scholar
• Kempermann G, Kuhn G, Gage F. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997; 386: 493–495
   PubMed Web of Science ®Google Scholar
• Kempermann G, Kuhn G, Gage F. Experience-induced neurogenesis in the senescent dentate gyrus. The Journal of Neuroscience 1998; 18: 3206–3212
   PubMed Web of Science ®Google Scholar
• Eriksson P, Bjork-Eriksson T, Alborn A, et al. Neurogenesis in the adult human hippocampus. Nature Medicine 1998; 4: 1313–1317
   PubMed Web of Science ®Google Scholar
• Friedland R. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with (18F) fluorodeoxyglucose. Journal of Computer Assisted Tomography 1983; 7: 590–598
   PubMed Web of Science ®Google Scholar
• Duara R. Positron emission tomography in Alzheimer's disease. Neurology 1986; 36: 879–887
   PubMed Web of Science ®Google Scholar
• Johnson K, Holman B, Rosen J, et al. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease. Archives of Internal Medicine 1990; 150(752–756. 1990)752–756, 150
   PubMedGoogle Scholar
• Hanyu H. Diagnostic accuracy of single photon emission compiled tomography in Alzheimer's Disease. Gerontology 1993; 39: 260–266
   PubMed Web of Science ®Google Scholar
• McMurdo M, Grant D, Kennedy N, et al. The valve of HMPAO SPECT scanning in the diagnosis of early Alzheimer's disease in patients attending a memory clinic. Nuclear Medicine Communications 1994; 15: 405–409
   PubMed Web of Science ®Google Scholar
• Osimani A. SPECT for differential diagnosis of dementia and correlation of RCBF with cognitive impairment. Canadian Journal of Neurological Sciences 1994; 21: 104–111
   PubMed Web of Science ®Google Scholar
• Kantarci K, Jack C, Xu Y, et al. egional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 2000; 55: 210–217
   PubMed Web of Science ®Google Scholar
• Heiss W. PET correlates of normal and impaired memory functions. Cerebrovascular and Brain Metabolism Reviews 1992; 4: 1–27
   PubMedGoogle Scholar
• Wolfe N, Reed B, Erberling J, et al. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. Archives of Neurology 1995; 53: 257–262
   Google Scholar
• Jagust W, Haan M, Eberling J, et al. Functional imaging predicts cognitive decline in Alzheimer's disease. Journal of Neuroimaging 1996; 6: 156–160
   PubMed Web of Science ®Google Scholar
• Kennedy A, Frackowiak R, Newman S, et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neuroscience Letters 1995; 186: 1720
   Web of Science ®Google Scholar
• Small G, Mazziota J, Collins M. Apolipoprotein E type 4 allele cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. Journal of the American Medical Association 1995; 273: 9424–9427
   Web of Science ®Google Scholar
• Celsis P. Age related cognitive decline: a clinical entity? A longitudinal study of regional cerebral blood flow and memory performance. Journal of Neurology, Neurosurgery and Psychiatry 1997; 62: 601–608
   PubMed Web of Science ®Google Scholar
• McKelvey R. Lack of prognostic significance of SPECT abnormalities in elderly subjects with a mild memory loss. Canadian Journal of Neurological Sciences 1999; 26: 23–28
   PubMed Web of Science ®Google Scholar
• Frackowiak R, Wise R, Gibbs J M, et al. Positron emission tomographic studies in aging and cerebrovascular disease at Hammersmith hospital. Annals of Neurology 1984; 15: S112–S118
   PubMed Web of Science ®Google Scholar
• Kuhl D, Metter E, Riege W, et al. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F] fluorodeoxyglucose method. Journal of Cerebral Blood Flow and Metabolism 1982; 2: 163–171
   PubMed Web of Science ®Google Scholar
• Martin A, Friston K, Colebatch J, et al. Decreases in regional cerebral blood flow with normal aging. Journal of Cerebral Blood Flow and Metabolism 1991; 11: 684–689
   PubMed Web of Science ®Google Scholar
• Leenders K Perani, Lammertsma A A, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 1990; 113: 27–34
   PubMed Web of Science ®Google Scholar
• Garraux G, Salmon E, Degueldre C, et al. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage 1999; 10: 149–162
   PubMed Web of Science ®Google Scholar
• Itoh M, Hatazawa J, Miyazawa H, et al. Stability of cerebral blood flow and oxygen metabolism during normal aging. Gerontology 1990; 36: 43–48
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Leonido-Yee M, et al. ighly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999; 53: 782–789
   PubMed Web of Science ®Google Scholar
• Meltzer C, Cantwell M, Greer P. Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. Journal of Nuclear Medicine 2000; 41: 1842–1848
   PubMed Web of Science ®Google Scholar
• Almkvist O. Functional brainimaging as a looking glass into the degraded brain: reviewing evidence from Alzheimer disease in relation to normal aging. Acta Psychologica 2000; 105: 255–277
   PubMed Web of Science ®Google Scholar
• Cabeza R. Age-related differences in neural activity during memory encoding and retrieval: a positron emission tomogrpahy study. Journal of Neuroscience 1997; 17: 391–400
   PubMed Web of Science ®Google Scholar
• Madden D, Turkington T, Provenzale J, et al. Adult age differences in the functional neuroanatomy of verbal recognition memory. Human Brain Mapping 1999; 7: 115–135
   PubMed Web of Science ®Google Scholar
• Grachev I D, Apkarian A V. Chemical Heterogeneity of the living human brain: a proton MR spectroscopy study of the effects of sex, age and brain region. Neuroimage 2000; 11: 554–563
   PubMed Web of Science ®Google Scholar
• Toft P. T1, T2 and concentrations of brain metabolites in neonates and adolescents estimated with h-1 MR spectroscopy. Journal of Magnetic Resonance Imaging 1994; 4: 1–5
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Poland R, et al. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sciences 1996; 58: 2049–2056
   PubMed Web of Science ®Google Scholar
• Cohen B, Renshaw P, Stoll A, et al. Decreased brain choline uptake in older adults: an in vivo proton magnetic resonance spectroscopy study. JAMA 1995; 274: 902–907
   PubMed Web of Science ®Google Scholar
• Charles H, Lazeyras F, Krishnan K. Proton spectroscopy of human brain: effects of age and sex. Progress in Neuro- Psychopharmacology and Biological Psychiatry 1994; 18: 995–1004
   PubMed Web of Science ®Google Scholar
• Leary S, Brex P, MacManus D, et al. (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. Magnetic Resonance Imaging 2000; 18: 455–459
   PubMed Web of Science ®Google Scholar
• Saunders D, Howe F, van den Boogaart A, et al. ging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. Journal of Magnetic Resonance Imaging 1999; 9: 711–716
   PubMed Web of Science ®Google Scholar
• Grachev I D, Apkarian A V. Aging alters regional multichemical profile of the human brain: an in vivo 1H-MRS study of young versus middle-aged subjects. Journal of Neurochemistry 1801; 76: 582–593
   Web of Science ®Google Scholar
• Angelie E, Bonmartin A, Boudraa A, et al. Regional differences and metabolic changes in normal aging of the human brain: proton mr spectroscopic imaging study. American Journal of Neuroradiology 1801; 22: 119–127
   Google Scholar
• Schuff N, Amend D, Knowlton R, et al. Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiology of Aging 1999; 20: 279–285
   PubMed Web of Science ®Google Scholar
• Valenzuela M, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology 1801; 56: 592–598
   Web of Science ®Google Scholar
• Rose S, de Zubicaray G, Wang D, et al. A 1H MRS Study of Probable Alzheimer's Disease and Normal Aging: Implications For Longitudinal Monitoring of Dementia Progression. Magnetic Resonance Imaging 1999; 17: 291–299
   PubMed Web of Science ®Google Scholar
• Christiansen P. Reduced N-acetyl-aspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magnetic Resonance Imaging 1995; 13: 457–463
   PubMed Web of Science ®Google Scholar
• Parnetti L, Tarducci R, Presciutti O, et al. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging. Mechanism of Ageing and Development 1997; 97: 9–14
   PubMed Web of Science ®Google Scholar
• Butterfield D A, Howard B, Yatin S, et al. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sciences 1999; 65: 1883–1892
   PubMed Web of Science ®Google Scholar
• Verkhratsky A. Calcium and neuronal ageing. Trends in Neuroscience 1998; 21: 2–7
   PubMed Web of Science ®Google Scholar
• Gareri P. Role of calcium in brain aging. General Pharmacology 1995; 26: 1651–1657
   PubMedGoogle Scholar
• Levere T. Old age and cognition: enhancement of recent memory in aged rats by the calcium channel blocker nimodipine. Neurobiology of Aging 1991; 13: 63–66
   Web of Science ®Google Scholar
• Tollefson G. Short-term effects of the calcium channel blocker nimodepine in the management of primary degenerative dementia. Biological Psychiatry 1990; 27: 1133–1142
   PubMed Web of Science ®Google Scholar
• Lee C K, Weindruch R, Prolla T A. Gene-expression profile of the ageing brain in mice. Nature Genetics 2000; 25: 294–297
   PubMed Web of Science ®Google Scholar
• Jiang C H, Tsien J Z, Schultz P G, et al. The effects of aging on gene expression in the hypothalamus and cortex of mice. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98: 1930–1934
   Google Scholar
• Masoro E J. Dietary Restriction. Experimental Gerontology 1995; 30: 291–298
   PubMed Web of Science ®Google Scholar
• Qu T, Uz T, Manev H. Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats. Neurobiology of Aging 2000; 21: 647–652
   PubMed Web of Science ®Google Scholar
• Deng G M, Su J H, Ivins K J, et al. Bcl-2 facilitates recovery from DNA damage after oxidative stress. Experimental Neurology 1999; 159: 309–318
   PubMed Web of Science ®Google Scholar
• Beal F, Hyman B, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?. Trends in Neurosciences 1993; 16: 125–131
   PubMed Web of Science ®Google Scholar
• Wallace D. Mitochondrial Genetics: a paradigm for aging and degenerative diseases?. Science 1992; 256: 628–632
   PubMed Web of Science ®Google Scholar
• Brewer G. Neuronal plasticity and stressor toxicity during aging. Experimental Gerontology 2000; 35: 1165–1183
   PubMed Web of Science ®Google Scholar
• Ojaimi J. Mitochondrial respiratory chain activity in the human brain as a function of age. Mechanism of Ageing and Development 1999; 111: 39–47
   PubMed Web of Science ®Google Scholar
• Chandrasekaran K. Evidence for physiological down-regulation of brain oxidative phsophorylation in Alzheimer's disease. Experimental Neurology 1996; 142: 80–88
   PubMed Web of Science ®Google Scholar
• Sapolsky R. Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Experimental Gerontology 1999; 34: 721–732
   PubMed Web of Science ®Google Scholar
• Starkman M, Gebarski S, Berent S, et al. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biological Psychiatry 1992; 32: 756–765
   PubMed Web of Science ®Google Scholar
• McEwen B, Sapolsky R. Stress and cognitive function. Current Opinion in Neurobiology 1995; 5: 205–216
   PubMed Web of Science ®Google Scholar
• Lupien S, Lecours A, Lussier I, et al. Basal cortisol levels and cognitive deficits in human aging. Journal of Neuroscience 1994; 14: 2893–2903
   PubMed Web of Science ®Google Scholar
• Lupien S, Leon M, De Santi S, et al. ortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neuroscience 1998; 1: 69–73
   PubMed Web of Science ®Google Scholar
• Seeman T, McEwen B, Singer B, et al. Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. Journal of Clinical Endocrinology and Metabolism 1997; 82: 2458–2465
   PubMed Web of Science ®Google Scholar
• Perry I. Prospective study of serum total homocysteine concentration and risk of stroke in middle aged British men. Lancet 1995; 346: 1395–1398
   PubMed Web of Science ®Google Scholar
• Selhub J. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New England Journal of Medicine 1995; 332: 286–291
   PubMed Web of Science ®Google Scholar
• McQuillan B, Beilby J, Nidorf M, et al. The risk of carotid atherosclerosis with hyperhomocysteinemia and the C677T mutation of the methylenetetrahydrofolate reductase. The Perth Carotid Ultrasound Assessment Study (CUDAS) Circulation 1999; 99: 2383–2388
   PubMed Web of Science ®Google Scholar
• Beilby J. Homocysteine and disease. Pathology 2000; 32: 262–273
   PubMed Web of Science ®Google Scholar
• Selhub J, Bagley L, Miller J, et al. B vitamins, homocysteine, and neurocognitive function in the elderly. American Journal of Clinical Nutrition 2000; 71: 614S–620S
   PubMed Web of Science ®Google Scholar
• Ravaglia G. Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment. Mechanisms of Ageing and Development 2000; 121:SI251–SI261
   Web of Science ®Google Scholar
• Clarke R. Folate, vitamin B12 and serum total homocysteine levels in confirmed Alzheimer's disease. Archives of Neurology 1998; 55: 1449–1455
   PubMed Web of Science ®Google Scholar
• McCaddon A, Davies G, Hudson P, et al. Total serum homocysteine in senile dementia of Alzheimer type. International Journal of Geriatric Psychiatry 1998; 13: 235–239
   PubMed Web of Science ®Google Scholar
• Whitehouse J. Effects of atropine on discrimination learning in the rat. Journal of Comparative and Physiological Psychology 1964; 57: 13–15
   PubMed Web of Science ®Google Scholar
• Deutsch J, Hamburg M, Dahl H, et al. Anticholinesterase –induced amnesia and its temporal aspects. Science 1996; 151: 221–223
   Web of Science ®Google Scholar
• Bartus R. Short term memory in the rhesus monkey: disruption from the anticholinergic scopalamine. Pharmacology, Biochemistry and Behaviour 1976; 5: 39–46
   PubMed Web of Science ®Google Scholar
• Hagan J, Jansen J, Broekamp C, et al. Blockade of spatial learning by the M1 Muscarinic antagonist pirenzepine. Psychopharmacology 1987; 93: 470–476
   PubMed Web of Science ®Google Scholar
• Caulfield M, Higgins G, Staughan D, et al. Central administation of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse. Journal of Pharmacy and Pharmacology 1983; 35: 131–132
   PubMed Web of Science ®Google Scholar
• Flicker C, Dean R, Watkins D, et al. Behavioural and Neurochemical Effects following neurotoxic lesion of a major cholinergic input to the cerebral cortex in the rat. Pharmacology, Biochemistry and Behaviour 1983; 18: 973–981
   PubMed Web of Science ®Google Scholar
• Sastry B, Janson V, Jaiswal N, et al. Changes in enzymes of the cholinergic system and acetylcholine release in the cerebra of aging male Fischer rats. Pharmacology 1983; 26: 61–72
   PubMed Web of Science ®Google Scholar
• Lippa A, Pelham R, Beer B, et al. Brain cholinergic dysfunction and memory in aged rats. Neurobiology of Aging 1980; 1: 13–19
   PubMed Web of Science ®Google Scholar
• Bowen D, Smith C, White P, et al. Neurotransmitter-related enzymes and indicies of hypoxia in senile dementia and other abiotrophies. Brain 1976; 99: 459–496
   PubMed Web of Science ®Google Scholar
• Op D V. Some cerebral proteins and enzyme systems in Alzheimer's presenile and senile dementia. Journal of the American Geriatric Society of 1976; 24: 12–16
   PubMed Web of Science ®Google Scholar
• Sims N, Bowen D, Smith C. Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease. Lancet 1980; 1: 333–336
   PubMed Web of Science ®Google Scholar
• Muller W. Central cholinergic function and aging. Acta Psychiatrica Scandinavica 1991; 366:S34–S39
   Web of Science ®Google Scholar
• Dewey S, Volkow N, Logan J. Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). Journal of Neuroscience Research 1990; 27: 569–575
   PubMed Web of Science ®Google Scholar
• Suhara T, Inoue O, Kobayashi K, et al. Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography. Neuroscience Letters 1993; 149: 225–228
   PubMed Web of Science ®Google Scholar
• Kelly J, Roth G. Changes in neurotransmitter signal transduction pathways in the aging bra. Advances in cell aging and gerontology, P Timiras, E Bittar. JAI, Greenwich 1997; 243–278
   Google Scholar
• Volkow N. Measuring age-related changes in DA D2 receptors with [11C] raclopride and with [18F] N-methylspiroperidol. Psychiatry Research 1996; 67: 11–16
   PubMed Web of Science ®Google Scholar
• Suhara T. Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology 1991; 103: 41–45
   PubMed Web of Science ®Google Scholar
• Volkow N, Ding Y-S, Fowler J. Dopamine transporters decrease with age in healthy subjects. Journal of Nuclear Medicine 1996; 37: 554–558
   PubMed Web of Science ®Google Scholar
• Volkow N, Gur R. Wang G–J. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. American Journal of Psychiatry 1998; 155: 344–349
   PubMed Web of Science ®Google Scholar
• Volkow N, Logan J, Fowler J, et al. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. American Journal of Psychiatry 2000; 157: 75–80
   PubMed Web of Science ®Google Scholar
• Rosier A. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using altanserin and positron emission tomographic imaging. Psychiatry Research 1996; 68: 11–22
   PubMed Web of Science ®Google Scholar
• Satz P. Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology 1993; 7: 273–295
   Google Scholar
• Mortimer J. Brain reserve and the clinical expression of Alzheimer's disease. Geriatrics 1997; 52:S50–S53
   PubMed Web of Science ®Google Scholar
• Schofield P, Mosesson R, Stern Y, et al. The age at onset of Alzheimer's disease ans an intracranial area measurement: a relationship. Archives of Neurology 1995; 52: 95–98
   PubMedGoogle Scholar
• Schofield P, Logroscino G, Andrews H, et al. An association between head cicumference and Alzheimer's disease in a population-based study of aging and dementia. Neurology 1997; 49: 30–37
   PubMed Web of Science ®Google Scholar
• Mori E, Hirono N, Yamashita H, et al. Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. American Journal of Psychiatry 1997; 154: 18–24
   PubMed Web of Science ®Google Scholar
• Graves A, Mortimer J, Larson E, et al. Head circumference as a measure of cognitive reserve association with severity of impairment in Alzheimer's disease. British Journal of Psychiatry 1996; 169: 86–92
   PubMed Web of Science ®Google Scholar
• Schofield P. Alzheimer's disease and brain reserve. Australasian Journal of on Ageing 1999; 18: 10–14
   Web of Science ®Google Scholar
• Katzman R. Education and the prevalence of dementia and Alzheiemer's disease. Neurology 1993; 43: 13–20
   PubMed Web of Science ®Google Scholar
• Mortimer J, Graves A. Education and other socioeconomic determinants of dementia and Alzheimer's disease. Neurology 1993; 43: 13–20
   PubMed Web of Science ®Google Scholar
• Ott A, Breteler M, van Harskamp F, et al. revalence of Alzheimer's disease and vascular dementia: association with education: the Rotterdam study. British Medical Journal of 1995; 310: 970–973
   PubMed Web of Science ®Google Scholar
• Farmer M, Kittner S, Rae D, et al. Education and change in cognitive function: the epidemiologic catchment area study. Annals of Epidemiology 1995; 5: 1–7
   PubMedGoogle Scholar
• Evans D, Beckett L, Albert M, et al. Level of education and change in cognitive function in a community population of older persons. Annals of Epidemiology 1993; 3: 71–77
   PubMedGoogle Scholar
• Plassman B, Welsh K, Helms M, et al. Intelligence and education as predictors of cognitive state in late life –a 5-year follow-up. Neurology 1995; 45: 1446–1450
   PubMed Web of Science ®Google Scholar
• Stern Y, Gurland B, Tatemichi T, et al. Influence of education and occupation on the incidence of Alzheimer's disease. Journal of the American Medical Association 1994; 271: 1004–1010
   PubMed Web of Science ®Google Scholar
• Anstey K. How important is mental activity in old age?. Australian Psychologist 1999; 34: 128–131
   Web of Science ®Google Scholar
• Hultsch D, Hertzog C, Small B, et al. Use it or lose it: engaged lifestyle as a buffer of cognitive decline in aging?. Psychology and Aging 1999; 14: 245–263
   PubMed Web of Science ®Google Scholar
• Schmand B, Smit J, Geerlings M, et al. The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis. Psychological Medicine 1997; 27: 1337–1344
   PubMed Web of Science ®Google Scholar
• Geerlings M, Deeg D, Penninx B, et al. Cognitive reserve and mortality in dementia: the role of cognition, functional ability and depression. Psychological Medicine 1999; 29: 1219–1226
   PubMed Web of Science ®Google Scholar
• Stern Y, Alexander G, Prohovnik I, et al. Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Annals of Neurology 1992; 32: 371–375
   PubMed Web of Science ®Google Scholar
• Stern Y, Alexander G, Stricks L, et al. Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology 1995; 45: 55–60
   PubMed Web of Science ®Google Scholar
• Timiras P. Education, homeostasis, and longevity. Experimental Gerontology 1995; 30: 189–198
   PubMed Web of Science ®Google Scholar
• Snowdon D, Kemper S, Mortimer J, et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. JAMA 1996; 275: 528–532
   PubMed Web of Science ®Google Scholar
• The Parkinson Study Group. Effects of tocopherol deprenyl on the progression of disability in early Parkinson's disease. New England Journal of Medicine 1993; 328: 176–183
   PubMed Web of Science ®Google Scholar
• Vatassery G. Vitamin E and other endogenous antioxidants in the central nervous system. Geriatrics 1998; 53:S25–S27
   PubMed Web of Science ®Google Scholar
• Lohr J. A double-blind placebo-controlled study of vitamin E treatment of Tardive Dyskinesia. Journal of Clinical Psychiatry 1996; 57: 167–173
   PubMed Web of Science ®Google Scholar
• Sano M. A controlled trial of selegiline, alpha-tocopherol, or both as a treatment for Alzheimer's disease. New England Journal of Medicine 1997; 336: 1216–1222
   PubMed Web of Science ®Google Scholar
• Peacock J, Folsom A, Knopman D, et al. Dietary antioxidant intake and cognitive performance in middle-age adults. Public Health Nutrition 2000; 3: 337–343
   PubMed Web of Science ®Google Scholar
• Mendelsohn A, Beele S, Stoehr G, et al. Use of antioxidants and its association with cognitive function in a rural elderly cohort-the movies project. American Journal of Epidemiology 1998; 148: 38–44
   PubMed Web of Science ®Google Scholar
• Compagnone N, Mellon S. Neurosteroids: biosynthesis and function of these novel neuromodulators. Frontiers in Neuroendocrinology 2000; 21: 1–56
   PubMed Web of Science ®Google Scholar
• Timiras P. Thyroid hormones and the developing bra. Handbook of human growth and developmental biology, E Meisami, P Timiras. CRC, New York 1988; 59–82
   Google Scholar
• Aniello F, Couchie D, Bridoux A, et al. Splicing of juvenile and adult tau mRNA variants is regulated by thryoid hormones. Proceeding of the National Academy of Sciences USA 1991; 88: 4035–4039
   PubMed Web of Science ®Google Scholar
• Confort C, Charrasse S, Clos J. Nerve growth factor enhances DNA synthesis in cultured cerebellar neuroblasts. Developmental Neuroscience 1991; 2: 566–568
   Google Scholar
• Denicoff H, Joffe R, Lakshmanan M, et al. Neuropsychiatric manifestations of altered thyroid state. American Journal of Psychiatry 1990; 147: 94–99
   PubMed Web of Science ®Google Scholar
• Tucker D, Penland J, Beckwith B, et al. Thyroid function in normals: Influences on the electroencephalogram and cognitive performance. Psychophysiology 1984; 21: 72–78
   PubMed Web of Science ®Google Scholar
• Wahlin A, Wahlin T, Small B, et al. Influences pf thyroid stimulating hormone on cognitive functioning in very old age. Journal of Gerontology: Psychological Sciences 1998; 53B: P234–P239
   Google Scholar
• Richards M, Kuh D, Hardy R, et al. Lifetime cognitive function and timing of the natural menopause. Neurology 1999; 53: 308–314
   PubMed Web of Science ®Google Scholar
• Palacios S, Cifuentes I, Menendez C, et al. The central nervous system and HRT. International Journal of Fertility and Womens Medicine 2000; 45: 13–21
   PubMedGoogle Scholar
• Sherwin B. Can estrogen keep you smart? Evidence from clinical studies. Journal of Psychiatry and Neuroscience 1999; 24: 315–321
   PubMed Web of Science ®Google Scholar
• Maki P, Resnick S. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiology of Aging 2000; 21: 373–383
   PubMed Web of Science ®Google Scholar
• Rice K, Morse C. Midlife memory: the role of HRT on the postmenopausal brain. The Ageing Brain: An International conference, Sydney, November, 3–4, 2000
   Google Scholar
• Wolf O, Preut R, Hellhammer D, et al. Testosterone and cognition in elderly men: a single testosterone injection blocks the practice effect in verbal fluency, but has not effect on spatial or verbal memory. Biological Psychiatry 2000; 47: 650–654
   PubMed Web of Science ®Google Scholar
• Sachdev P, Valenzuela M, Wang X, et al. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology, (in press)
   Google Scholar